Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
ConditionCardiovascular Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLinkoeping University
About this trial
The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life.
Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months. Patients randomised to the Heart-eXg group will receive an exergame with feedback and tailoring to adapt the exergaming advice. Patients will also be able to play with a person in their own network.
Eligibility criteria
Qualifiers
Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection fraction (HFrEF) can be included.
Clinically stable
Physically inactive
Older than 18 years, there is no upper age limit,
Disqualifiers
Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist.
Not being able to perform the 6-minute walk test.
Not being able or willing to wear an activity monitor.
Currently included in a rehabilitation program
Trial design
Treatments tested in this trial
- Heart Farming
Treatment groups
750 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov